ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies Filippo ConsonniEleonora GambineriClaudio Favre Review Article Open access 20 January 2022 Pages: 469 - 484
Castleman disease and TAFRO syndrome Yasufumi MasakiKotaro AritaHiroshi Kawabata Review Article 19 January 2022 Pages: 485 - 490
Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus Larissa HenzeChristoph BuhlMarie von Lilienfeld-Toal Original Article Open access 07 January 2022 Pages: 491 - 511
Hemophagocytosis, hyper-inflammatory responses, and multiple organ damages in COVID-19-associated hyperferritinemia Guiying DongJianbo YuTianbing Wang Original Article Open access 04 December 2021 Pages: 513 - 520
Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study Selen BayraktarogluNihal KaradasYesim Aydinok Original Article 05 January 2022 Pages: 521 - 529
Correction to: Modern management of iron overload in thalassemia major patients guided by MRI techniques: real‑world data from a long‑term cohort study Selen BayraktarogluNihal KaradasYesim Aydinok Correction 14 January 2022 Pages: 531 - 531
The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease Denis SoulièresJules Mercier-RossFernando Tricta Original Article Open access 04 January 2022 Pages: 533 - 539
Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease Seda S. ToluAndrew CrouchCaterina P. Minniti Original Article 18 January 2022 Pages: 541 - 548
Red cell ektacytometry in two patients with chronic hemolytic anemia and three new α-spectrin variants Joan-Lluis Vives-CorronsElena KrishnevskayaIsabel Badell Original Article 29 November 2021 Pages: 549 - 555
Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes Amer M. ZeidanDaniel J. DeAngeloWendy Stock Original Article 04 January 2022 Pages: 557 - 569
Genetic diversity within leukemia-associated immunophenotype-defined subclones in AML F. TisoT. N. Koorenhof-ScheeleJ. H. Jansen Original Article Open access 13 January 2022 Pages: 571 - 579
Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocol Danielle FredmanYakir MosheJonathan Canaani Original Article 28 January 2022 Pages: 581 - 593
Optimization of high-dose methotrexate prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma: a multicenter analysis Yu FangNing SuQingqing Cai Original Article 05 January 2022 Pages: 595 - 605
First-line high-dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas—a single-centre experience in 61 patients T. BrezinaH. von DewitzG. Kobbe Original Article Open access 04 January 2022 Pages: 607 - 616
First report of successful treatment for hemoglobin Bristol-Alesha by hemopoietic stem cell transplantation Shanshan LiKai ChenShayi Jiang Original Article 01 December 2021 Pages: 617 - 619
Elevated REG3α predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy Jingjing YangBo PengDaihong Liu Original Article 23 November 2021 Pages: 621 - 630
Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area Yibo WuYi ChenYi Luo Original Article 04 January 2022 Pages: 631 - 641
Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia Kaito HaradaShohei MizunoMasamitsu Yanada Original Article 06 January 2022 Pages: 643 - 653
Busulfan–fludarabine- or treosulfan–fludarabine-based myeloablative conditioning for children with thalassemia major Roswitha LüftingerNatalia Zubarovskayaon behalf of the EBMT Pediatric Diseases, Inborn Errors Working Parties Original Article 09 January 2022 Pages: 655 - 665
Fixed-dose administration and pharmacokinetically guided adjustment of busulfan dose for patients undergoing hematopoietic stem cell transplantation: a meta-analysis and cost-effectiveness analysis Tingting ChenChaoxin ChenBin Zheng Original Article 29 January 2022 Pages: 667 - 679
Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation Judith SchaffrathTanja DiederichsLutz P. Müller Original Article Open access 21 December 2021 Pages: 681 - 691
Hepatic sinusoidal obstruction syndrome post-chemotherapy in pediatric and adolescent age: case series of six patients in Qatar Tayseer AlSaadTayseer YousifChiara Cugno Letter to the Editor 21 April 2021 Pages: 693 - 695
Venetoclax and decitabine in refractory TP53-mutated early T-cell precursor acute lymphoblastic leukemia Jinyu KongNan ChenHuiying Qiu Letter to the Editor 06 May 2021 Pages: 697 - 699
A new case of Bicêtre hemoglobin in an adult male: clinical observations over a period of four years Giovanna Farfán-QuirogaMaria del Mar Hermosilla-FernandezRicardo García-Muñoz Letter to the Editor 11 May 2021 Pages: 701 - 702
Successful treatment of hairy cell leukemia variant with obinutuzumab Diana Al-SarayfiFreek O. MeeuwesMarcel Nijland Letter to the Editor Open access 04 June 2021 Pages: 703 - 704
Next-generation sequencing redefines the diagnosis of triple-negative myeloproliferative neoplasms Sanyun WuPing LuoXuelan Zuo Letter to the Editor 13 September 2021 Pages: 705 - 708
Liquid biopsies of plasma and cerebrospinal fluid are useful for detection of intravascular lymphoma with central nervous system symptoms alone Hiroki HosoiIkuro TanigawaTakashi Sonoki Letter to the Editor 03 July 2021 Pages: 709 - 711
Reduced bendamustine for elderly patients with follicular lymphoma Yosuke MasamotoArika ShimuraMineo Kurokawa Letter to the Editor 21 June 2021 Pages: 713 - 715
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine Johannes RuheUlf SchnetzkeGunter Wolf Letter to the Editor Open access 26 July 2021 Pages: 717 - 719
Aggressive NK-cell leukemia with hemophagocytosis in a Caucasian patient Simon MichaelisAngelika PichlerDietmar Enko Letter to the Editor 16 July 2021 Pages: 721 - 722
Successful ibrutinib treatment for central nervous system relapse of chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation Tomohiko TanigawaMasatoshi SakuraiKeisuke Kataoka Letter to the Editor 08 July 2021 Pages: 723 - 724
TTP or complement-mediated TMA or both? A rare diagnosis and report of a novel plasminogen gene variant Nishant R. TiwariSankalp AroraVivek R. Sharma Letter to the Editor 16 July 2021 Pages: 725 - 727
The added value of digital morphological analysis in the evaluation of peripheral blood films: the report of an UKNEQAS external quality assessment sample Marco RosettiBarbara De la SalleRomolo M. Dorizzi Letter to the Editor 10 July 2021 Pages: 729 - 730
